Relationship Between Polymorphisms in Methotrexate Pathway Genes and Outcome of Methotrexate Treatment in a Cohort of 119 Patients with Juvenile Idiopathic Arthritis.

Zajc Avramovič, Mojca

Relationship Between Polymorphisms in Methotrexate Pathway Genes and Outcome of Methotrexate Treatment in a Cohort of 119 Patients with Juvenile Idiopathic Arthritis. [electronic resource] - The Journal of rheumatology 08 2017 - 1216-1223 p. digital

Publication Type: Journal Article

1499-2752

10.3899/jrheum.160950 doi


AMP Deaminase--genetics
ATP Binding Cassette Transporter, Subfamily G, Member 2--genetics
Antirheumatic Agents--therapeutic use
Arthritis, Juvenile--diagnostic imaging
Child
Child, Preschool
Female
Ferredoxin-NADP Reductase--genetics
Genotype
Humans
Infant
Male
Methotrexate--therapeutic use
Methylenetetrahydrofolate Dehydrogenase (NADP)--genetics
Methylenetetrahydrofolate Reductase (NADPH2)--genetics
Minor Histocompatibility Antigens--genetics
Multidrug Resistance-Associated Protein 2
Neoplasm Proteins--genetics
Pharmacogenetics
Polymorphism, Single Nucleotide
Severity of Illness Index
Treatment Outcome